Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V., a leading biopharmaceutical company headquartered in Ireland (IE), focuses on developing innovative treatments for gastrointestinal diseases and other specialised areas. Founded in 1997, Cosmo has established a strong presence in Europe and the United States, with significant operational activities in these key markets. The company is renowned for its unique drug delivery technologies, particularly in the field of endoscopy and gastrointestinal health. Its flagship products, including the advanced bowel preparation agent and proprietary drug formulations, set Cosmo apart in the competitive pharmaceutical landscape. With a commitment to research and development, Cosmo Pharmaceuticals has achieved notable milestones, positioning itself as a trusted name in the biopharmaceutical industry.
DitchCarbon Score
How does Cosmo Pharmaceuticals N.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cosmo Pharmaceuticals N.V.'s score of 13 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cosmo Pharmaceuticals N.V.'s reported carbon emissions
Cosmo Pharmaceuticals N.V., headquartered in Ireland (IE), currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of concrete data, it is essential for stakeholders to monitor future disclosures regarding Cosmo Pharmaceuticals' climate commitments and sustainability strategies.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cosmo Pharmaceuticals N.V. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
